US Stock MarketDetailed Quotes

Apellis Pharmaceuticals (APLS)

Watchlist
  • 20.530
  • +0.200+0.98%
Close Jan 15 16:00 ET
  • 20.530
  • 0.0000.00%
Post 20:01 ET
2.60BMarket Cap57.03P/E (TTM)

Apellis Pharmaceuticals (APLS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
218.13%108.47M
153.30%4.45M
59.84%-53.41M
85.23%-87.87M
119.78%19.36M
120.17%34.1M
94.45%-8.34M
25.13%-132.98M
-15.76%-594.74M
30.46%-97.88M
Net income from continuing operations
475.52%215.72M
-11.93%-42.15M
-38.84%-92.23M
62.57%-197.88M
58.96%-36.35M
59.04%-57.45M
69.14%-37.66M
62.64%-66.42M
18.94%-528.63M
46.64%-88.58M
Operating gains losses
----
----
----
1,524.17%1.95M
--0
--0
----
----
-99.64%120K
---32K
Depreciation and amortization
-25.82%339K
-0.67%446K
0.45%446K
0.73%1.8M
-21.58%447K
12.84%457K
9.51%449K
11.28%444K
14.95%1.78M
15.62%570K
Other non cash items
-3.34%636K
-80.24%614K
-90.38%591K
-60.08%10.5M
-91.08%587K
-89.86%658K
-52.32%3.11M
-8.41%6.14M
-8.27%26.29M
31.63%6.58M
Change In working capital
-316.69%-136.41M
396.84%18.34M
110.05%10.4M
90.83%-18.36M
166.53%28.37M
209.48%62.95M
90.40%-6.18M
-189.18%-103.5M
-1,170.37%-200.25M
-850.42%-42.64M
-Change in receivables
-616.91%-131.4M
157.74%21.12M
148.33%29.68M
70.57%-58.48M
137.89%14.09M
143.56%25.42M
53.94%-36.58M
-158.28%-61.42M
-8,466.95%-198.72M
-10,284.38%-37.17M
-Change in inventory
-37.59%5.4M
-79.24%-26.01M
193.81%14M
82.27%-10.76M
120.96%10.02M
85.29%8.66M
17.77%-14.51M
-10,461.81%-14.92M
12.61%-60.65M
-84.18%-47.82M
-Change in prepaid assets
-145.93%-2.38M
-43.87%7.95M
-331.67%-18.73M
1,191.98%20.42M
-7.11%5.4M
150.80%5.19M
436.34%14.17M
-3,954.21%-4.34M
83.71%-1.87M
197.06%5.81M
-Change in payables and accrued expense
-156.25%-8.56M
-34.83%21.84M
63.72%-13.45M
-45.21%19.24M
-75.95%7.57M
45.90%15.22M
48.67%33.51M
-26.38%-37.06M
183.75%35.12M
-17.35%31.47M
-Change in other current assets
538.83%5.35M
-538.14%-6.78M
-110.27%-1.11M
-55.68%11.5M
-81.98%928K
120.76%837K
-114.07%-1.06M
-37.52%10.8M
-48.55%25.94M
147.19%5.15M
-Change in other working capital
93.50%-113K
112.56%215K
-99.80%7K
-246.25%-277K
---270K
---1.74M
---1.71M
--3.44M
-23.08%-80K
----
Cash from discontinued investing activities
Operating cash flow
218.13%108.47M
153.30%4.45M
59.84%-53.41M
85.23%-87.87M
119.78%19.36M
120.17%34.1M
94.45%-8.34M
25.13%-132.98M
-15.76%-594.74M
30.46%-97.88M
Investing cash flow
Cash flow from continuing investing activities
-148K
45.56%-49K
97.27%-8K
40.21%-403K
-600.00%-20K
0
75.81%-90K
-13.13%-293K
-101.13%-674K
-100.00%4K
Net PPE purchase and sale
---148K
45.56%-49K
97.27%-8K
40.21%-403K
-600.00%-20K
--0
75.81%-90K
-13.13%-293K
55.77%-674K
100.47%4K
Net investment purchase and sale
----
----
----
--0
----
----
----
----
--0
----
Cash from discontinued investing activities
Investing cash flow
---148K
45.56%-49K
97.27%-8K
40.21%-403K
-600.00%-20K
--0
75.81%-90K
-13.13%-293K
-101.13%-674K
-100.00%4K
Financing cash flow
Cash flow from continuing financing activities
-68.80%793K
-84.56%6.56M
-99.75%274K
-62.17%149.24M
-2.22%-4M
-55.76%2.54M
2,623.53%42.49M
-72.33%108.21M
7.89%394.5M
75.46%-3.91M
Net issuance payments of debt
--0
----
----
--365.45M
--0
--0
----
----
--0
--0
Net common stock issuance
----
----
----
--0
--0
--0
---98.76M
-74.31%98.76M
1.12%384.39M
--0
Proceeds from stock option exercised by employees
-68.82%797K
27.22%6.56M
-97.03%281K
-75.44%18.83M
-93.95%1.64M
-55.60%2.56M
-80.24%5.16M
-46.51%9.48M
198.01%76.65M
616.45%27.09M
Net other financing activities
71.43%-4K
--0
-100.01%-7K
-253.23%-235.04M
81.81%-5.64M
-27.27%-14K
-1,237.74%-328.12M
997.67%98.74M
-65.60%-66.54M
-57.16%-31M
Cash from discontinued financing activities
Financing cash flow
-68.80%793K
-84.56%6.56M
-99.75%274K
-62.17%149.24M
-2.22%-4M
-55.76%2.54M
2,623.53%42.49M
-72.33%108.21M
7.89%394.5M
75.46%-3.91M
Net cash flow
Beginning cash position
2.78%371.47M
10.03%359.83M
17.12%412.61M
-36.30%352.3M
-12.19%398.24M
-41.45%361.43M
-57.33%327.03M
-36.30%352.3M
-13.82%553.07M
-22.54%453.5M
Current changes in cash
197.81%109.11M
-67.84%10.95M
-112.03%-53.14M
130.35%60.97M
115.07%15.34M
122.42%36.64M
122.86%34.06M
-111.75%-25.06M
-127.81%-200.91M
-212.59%-101.78M
Effect of exchange rate changes
-87.28%22K
100.29%685K
271.77%359K
-588.15%-659K
-265.24%-965K
137.77%173K
827.66%342K
-473.21%-209K
127.66%135K
212.30%584K
End cash Position
20.68%480.6M
2.78%371.47M
10.03%359.83M
17.12%412.61M
17.12%412.61M
-12.19%398.24M
-41.45%361.43M
-57.33%327.03M
-36.30%352.3M
-36.30%352.3M
Free cash flow
217.69%108.32M
152.15%4.4M
59.92%-53.42M
85.18%-88.27M
119.74%19.34M
120.16%34.1M
94.40%-8.43M
25.07%-133.28M
-15.57%-595.51M
30.81%-97.97M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 218.13%108.47M153.30%4.45M59.84%-53.41M85.23%-87.87M119.78%19.36M120.17%34.1M94.45%-8.34M25.13%-132.98M-15.76%-594.74M30.46%-97.88M
Net income from continuing operations 475.52%215.72M-11.93%-42.15M-38.84%-92.23M62.57%-197.88M58.96%-36.35M59.04%-57.45M69.14%-37.66M62.64%-66.42M18.94%-528.63M46.64%-88.58M
Operating gains losses ------------1,524.17%1.95M--0--0---------99.64%120K---32K
Depreciation and amortization -25.82%339K-0.67%446K0.45%446K0.73%1.8M-21.58%447K12.84%457K9.51%449K11.28%444K14.95%1.78M15.62%570K
Other non cash items -3.34%636K-80.24%614K-90.38%591K-60.08%10.5M-91.08%587K-89.86%658K-52.32%3.11M-8.41%6.14M-8.27%26.29M31.63%6.58M
Change In working capital -316.69%-136.41M396.84%18.34M110.05%10.4M90.83%-18.36M166.53%28.37M209.48%62.95M90.40%-6.18M-189.18%-103.5M-1,170.37%-200.25M-850.42%-42.64M
-Change in receivables -616.91%-131.4M157.74%21.12M148.33%29.68M70.57%-58.48M137.89%14.09M143.56%25.42M53.94%-36.58M-158.28%-61.42M-8,466.95%-198.72M-10,284.38%-37.17M
-Change in inventory -37.59%5.4M-79.24%-26.01M193.81%14M82.27%-10.76M120.96%10.02M85.29%8.66M17.77%-14.51M-10,461.81%-14.92M12.61%-60.65M-84.18%-47.82M
-Change in prepaid assets -145.93%-2.38M-43.87%7.95M-331.67%-18.73M1,191.98%20.42M-7.11%5.4M150.80%5.19M436.34%14.17M-3,954.21%-4.34M83.71%-1.87M197.06%5.81M
-Change in payables and accrued expense -156.25%-8.56M-34.83%21.84M63.72%-13.45M-45.21%19.24M-75.95%7.57M45.90%15.22M48.67%33.51M-26.38%-37.06M183.75%35.12M-17.35%31.47M
-Change in other current assets 538.83%5.35M-538.14%-6.78M-110.27%-1.11M-55.68%11.5M-81.98%928K120.76%837K-114.07%-1.06M-37.52%10.8M-48.55%25.94M147.19%5.15M
-Change in other working capital 93.50%-113K112.56%215K-99.80%7K-246.25%-277K---270K---1.74M---1.71M--3.44M-23.08%-80K----
Cash from discontinued investing activities
Operating cash flow 218.13%108.47M153.30%4.45M59.84%-53.41M85.23%-87.87M119.78%19.36M120.17%34.1M94.45%-8.34M25.13%-132.98M-15.76%-594.74M30.46%-97.88M
Investing cash flow
Cash flow from continuing investing activities -148K45.56%-49K97.27%-8K40.21%-403K-600.00%-20K075.81%-90K-13.13%-293K-101.13%-674K-100.00%4K
Net PPE purchase and sale ---148K45.56%-49K97.27%-8K40.21%-403K-600.00%-20K--075.81%-90K-13.13%-293K55.77%-674K100.47%4K
Net investment purchase and sale --------------0------------------0----
Cash from discontinued investing activities
Investing cash flow ---148K45.56%-49K97.27%-8K40.21%-403K-600.00%-20K--075.81%-90K-13.13%-293K-101.13%-674K-100.00%4K
Financing cash flow
Cash flow from continuing financing activities -68.80%793K-84.56%6.56M-99.75%274K-62.17%149.24M-2.22%-4M-55.76%2.54M2,623.53%42.49M-72.33%108.21M7.89%394.5M75.46%-3.91M
Net issuance payments of debt --0----------365.45M--0--0----------0--0
Net common stock issuance --------------0--0--0---98.76M-74.31%98.76M1.12%384.39M--0
Proceeds from stock option exercised by employees -68.82%797K27.22%6.56M-97.03%281K-75.44%18.83M-93.95%1.64M-55.60%2.56M-80.24%5.16M-46.51%9.48M198.01%76.65M616.45%27.09M
Net other financing activities 71.43%-4K--0-100.01%-7K-253.23%-235.04M81.81%-5.64M-27.27%-14K-1,237.74%-328.12M997.67%98.74M-65.60%-66.54M-57.16%-31M
Cash from discontinued financing activities
Financing cash flow -68.80%793K-84.56%6.56M-99.75%274K-62.17%149.24M-2.22%-4M-55.76%2.54M2,623.53%42.49M-72.33%108.21M7.89%394.5M75.46%-3.91M
Net cash flow
Beginning cash position 2.78%371.47M10.03%359.83M17.12%412.61M-36.30%352.3M-12.19%398.24M-41.45%361.43M-57.33%327.03M-36.30%352.3M-13.82%553.07M-22.54%453.5M
Current changes in cash 197.81%109.11M-67.84%10.95M-112.03%-53.14M130.35%60.97M115.07%15.34M122.42%36.64M122.86%34.06M-111.75%-25.06M-127.81%-200.91M-212.59%-101.78M
Effect of exchange rate changes -87.28%22K100.29%685K271.77%359K-588.15%-659K-265.24%-965K137.77%173K827.66%342K-473.21%-209K127.66%135K212.30%584K
End cash Position 20.68%480.6M2.78%371.47M10.03%359.83M17.12%412.61M17.12%412.61M-12.19%398.24M-41.45%361.43M-57.33%327.03M-36.30%352.3M-36.30%352.3M
Free cash flow 217.69%108.32M152.15%4.4M59.92%-53.42M85.18%-88.27M119.74%19.34M120.16%34.1M94.40%-8.43M25.07%-133.28M-15.57%-595.51M30.81%-97.97M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More